Bioscope.AI Names Dr. Helen Messier to Drive the Future of Clinical AI as Chief Medical Officer

CARMEL, Ind., February 3, 2026 (Newswire.com) - Bioscope.AI, a pioneer in clinical AI-powered medicine solutions, today announced the appointment of Helen Messier, PhD, MD, as Chief Medical Officer.

"Dr Messier is one of the leading medical professionals helping to reshape the future of medicine" said Dr. Donald E. Brown, Founder and CEO of Bioscope.AI. "Dr. Messier's knowledge and innovative approach to solving some of the most complex health issues of today, coupled with her industry connections and presence will be a great boost to Bioscope as we solve the core challenge at the heart of precision medicine: transforming vast, multidimensional patient data into clear, actionable insight, so physicians can make smarter, faster, more personalized decisions across every dimension of health."

Dr. Helen Messier is a physician-scientist and nationally recognized leader in precision and longevity medicine, with expertise spanning family medicine, molecular biology, and unique models of care delivery. Holding a PhD in molecular immunology alongside her MD, her work centers on moving medicine upstream toward understanding root cause. A pioneer in bringing multi-omics and AI into clinical practice, she has helped make complex biological data actionable for clinicians and patients. She has founded a national network of concierge medical practices and Medical Intelligence Learning Labs Inc., and has led genomic strategy at Human Longevity Inc. and served as Chief Medical Officer at Viome and Chief Medical and Science Officer at Fountain Life. Dr. Messier continues to support practicing clinicians through service on scientific advisory boards and her long-standing role as educator with the Institute for Functional Medicine, and is a sought-after speaker on AI, longevity medicine, and women's health, known for translating advanced science into care that is both precise and deeply human-centered.

"Throughout my career, I've focused on bridging advanced biology with real-world clinical care to help physicians move from reactive treatment to proactive, personalized medicine," said Helen Messier, Chief Medical Officer of Bioscope.AI. "What excites me about Bioscope is its ability to bring together multi-omics, AI, and clinical intelligence in a truly integrated way. This platform has the potential to make complex data usable at the point of care and support physicians in delivering more precise, preventive, and deeply human-centered medicine. I'm thrilled to be joining the Bioscope team."

Bioscope.AI is a pioneer in AI-powered omics medicine. The company leverages artificial intelligence, genomics, and advanced diagnostics to help physicians prevent disease rather than simply treat it. When disease does occur, Bioscope enables earlier detection and clearer clinical insight, empowering physicians to help patients live longer, healthier lives. To learn more, visit www.bioscope.ai Press inquires contact Joe Staples - [email protected]

SOURCE: Bioscope.AI

Source: Bioscope.AI